Cutamesine, also known as SA-4503 and AGY94806, is a sigma-1 receptor agonist under development for recovery enhancement after acute ischemic stroke. Cutamesine protects against retinal cell death in vitro and in vivo by the agonistic effect of sigma-1 receptor. Therefore, sigma-1 receptor may have a potential as a therapeutic target in retinal diseases mediated by photoreceptor degeneration.
Cutamesine dihydrochloride (SA4503 dihydrochloride; AGY94806 dihydrochloride) is a potent Sigma 1 receptor agonist with an IC50 of 17.4 nM in guinea pig brain membranes.
Properties:
Boiling Point: 499.2ºC at 760 mmHg
Flash Point: 137.3ºC
Vapor Pressure: 4.25E-10mmHg at 25°C
Sigma Receptor Related Products:
Siramesine HCl; Blonanserin; S1RA(E-52862); Siramesine(Lu 28-179); S1RA hydrochloride